rs41278788

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_194454.3(KRIT1):​c.1245T>G​(p.Ile415Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00159 in 1,543,714 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I415F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0019 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 8 hom. )

Consequence

KRIT1
NM_194454.3 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.148

Publications

2 publications found
Variant links:
Genes affected
KRIT1 (HGNC:1573): (KRIT1 ankyrin repeat containing) This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]
KRIT1 Gene-Disease associations (from GenCC):
  • cerebral cavernous malformation 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • famililal cerebral cavernous malformations
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_194454.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065103173).
BP6
Variant 7-92225729-A-C is Benign according to our data. Variant chr7-92225729-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 360884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00185 (282/152260) while in subpopulation NFE AF = 0.00143 (97/68008). AF 95% confidence interval is 0.0012. There are 2 homozygotes in GnomAd4. There are 190 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 282 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_194454.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KRIT1
NM_194454.3
MANE Select
c.1245T>Gp.Ile415Met
missense
Exon 12 of 19NP_919436.1O00522-1
KRIT1
NM_001350672.1
c.1245T>Gp.Ile415Met
missense
Exon 10 of 17NP_001337601.1O00522-1
KRIT1
NM_001350673.1
c.1245T>Gp.Ile415Met
missense
Exon 11 of 18NP_001337602.1O00522-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KRIT1
ENST00000394505.7
TSL:1 MANE Select
c.1245T>Gp.Ile415Met
missense
Exon 12 of 19ENSP00000378013.2O00522-1
ENSG00000289027
ENST00000692281.1
c.1245T>Gp.Ile415Met
missense
Exon 12 of 26ENSP00000510568.1A0A8I5KWQ7
ENSG00000285953
ENST00000458493.6
TSL:4
c.1245T>Gp.Ile415Met
missense
Exon 11 of 20ENSP00000396352.2C9JD81

Frequencies

GnomAD3 genomes
AF:
0.00185
AC:
282
AN:
152142
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0162
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00143
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00239
AC:
601
AN:
251212
AF XY:
0.00231
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0174
Gnomad NFE exome
AF:
0.00176
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00156
AC:
2177
AN:
1391454
Hom.:
8
Cov.:
26
AF XY:
0.00148
AC XY:
1033
AN XY:
696572
show subpopulations
African (AFR)
AF:
0.0000624
AC:
2
AN:
32074
American (AMR)
AF:
0.0000896
AC:
4
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.0000389
AC:
1
AN:
25726
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39320
South Asian (SAS)
AF:
0.000318
AC:
27
AN:
84790
European-Finnish (FIN)
AF:
0.0152
AC:
811
AN:
53306
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5052
European-Non Finnish (NFE)
AF:
0.00119
AC:
1244
AN:
1048510
Other (OTH)
AF:
0.00152
AC:
88
AN:
58020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
95
190
286
381
476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00185
AC:
282
AN:
152260
Hom.:
2
Cov.:
32
AF XY:
0.00255
AC XY:
190
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41568
American (AMR)
AF:
0.000262
AC:
4
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.0162
AC:
172
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00143
AC:
97
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.000714
EpiCase
AF:
0.000981
EpiControl
AF:
0.00130

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Cerebral cavernous malformation (3)
-
-
2
not provided (2)
-
-
1
Angiokeratoma corporis diffusum with arteriovenous fistulas (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
3.9
DANN
Benign
0.89
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.75
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0065
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.15
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.027
Sift
Benign
0.082
T
Sift4G
Benign
0.16
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.35
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41278788;
hg19: chr7-91855043;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.